WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997035569) USE OF HEME OXYGENASE INHIBITORS TO TREAT CANCER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/035569    International Application No.:    PCT/GB1997/000844
Publication Date: 02.10.1997 International Filing Date: 26.03.1997
Chapter 2 Demand Filed:    28.09.1997    
IPC:
A61K 31/00 (2006.01), A61K 31/198 (2006.01), A61K 31/223 (2006.01), A61K 31/295 (2006.01), A61K 31/555 (2006.01), A61K 45/06 (2006.01)
Applicants: WILLIAM HARVEY RESEARCH LIMITED [GB/GB]; Saint Bartholomew and The Royal Hospital School of Medicine and Dentistry, Charterhouse Square, London EC1 6BQ (GB) (For All Designated States Except US).
MOORE, Adrian, Richard [GB/GB]; (GB) (For US Only).
WILLIS, Dean [GB/GB]; (GB) (For US Only).
WILLOUGHBY, Derek, Albert [GB/GB]; (GB) (For US Only)
Inventors: MOORE, Adrian, Richard; (GB).
WILLIS, Dean; (GB).
WILLOUGHBY, Derek, Albert; (GB)
Agent: SCHLICH, George, William; Mathys & Squire, 100 Gray's Inn Road, London WC1X 8AL (GB)
Priority Data:
9606293.0 26.03.1996 GB
Title (EN) USE OF HEME OXYGENASE INHIBITORS TO TREAT CANCER
(FR) EMPLOI D'INHIBITEURS DE L'HEME-OXYGENASE POUR LE TRAITEMENT DES CANCERS
Abstract: front page image
(EN)An inhibitor of heme oxygenase is used in treatment of cancers and other tumours, either alone or in combination with another anti-tumour agent or as non-pharmaceutical anti-tumour therapy such as tumour irradiation. An anti-tumour composition comprises an inhibitor of heme oxygenase and a cytotoxic agent.
(FR)Un inhibiteur de l'hème-oxygénase est employé pour le traitement des cancers et d'autres tumeurs, soit seul soit en association avec d'autres agents antitumoraux, ou dans le cadre d'une thérapie antitumorale non pharmaceutique telle que la radioexposition des tumeurs. L'invention concerne aussi une composition antitumorale comprenant un inhibiteur de l'hème-oxygénase et un agent cytotoxique.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, HU, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TR, TT, UA, UG, US, UZ, VN.
African Regional Intellectual Property Organization (GH, KE, LS, MW, SD, SZ, UG)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)